Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Human Versican V0, V1 Neo (aa 436-441) Synthetic Peptide

Catalog No. PEP235
Click to view available options
Quantity:
50 μg

Synthetic Peptide

Human Versican (residues 436-441) Synthetic Peptide, PEP-235, from Invitrogen.

Versican is a member of the family of large aggregating proteoglycans (also including aggrecan, brevican, and neurocan). The protein shows wide tissue distribution which includes fibrous, articular, and elastic cartilages, as well as nervous, epidermal, arterial, and loose connective tissues. Versican V1 has been shown to enhance cell proliferation, and also induce cell transformation and protect cells from apoptosis. This was demonstrated through its ability to downregulate the expression of proapoptotic Bad. Versican's existence as a extracellular matrix protein in human airways has also lead to the discovery of an inflammatory role in asthmatics.
TRUSTED_SUSTAINABILITY

Specifications

Gene ID (Entrez) 1462
Species Human
Purification Method purified
Accession Number P13611
Common Name Human Versican V0, V1 Neo (aa 436-441)
Concentration 0.5 mg/mL
Content And Storage -20°C. Avoid freeze-thaw cycles.
Description Synthetic Peptide
Format Lyophilized
Formulation peptide with no preservative
For Use With (Application) Control
Gene Symbol VCAN
Lyophilized Lyophilized
Preservative No preservative
Product Type Peptide
Quantity 50 μg
Regulatory Status RUO - research use only
Sequence C G G D(436) P E A A E(441)
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.